Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37734869)

  • 1. Glioblastoma cellular MAP4K1 facilitates tumor growth and disrupts T effector cell infiltration.
    Sun JM; Fan HY; Zhu Y; Pan TT; Wu YP; Zhang DY; Hou XY
    Life Sci Alliance; 2023 Dec; 6(12):. PubMed ID: 37734869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.
    Ren J; Zheng S; Zhang L; Liu J; Cao H; Wu S; Xu Y; Sun J
    Cancer Med; 2023 May; 12(10):11624-11640. PubMed ID: 36999945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.
    Sun J; Xu Y; Liu J; Cui H; Cao H; Ren J
    Cancer Sci; 2022 Feb; 113(2):500-516. PubMed ID: 34812552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway.
    Bhardwaj R; Suzuki A; Leland P; Joshi BH; Puri RK
    J Transl Med; 2018 Dec; 16(1):369. PubMed ID: 30572904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated ETV6 Expression in Glioma Promotes an Aggressive In Vitro Phenotype Associated with Shorter Patient Survival.
    Xiong Z; Wu S; Li FJ; Luo C; Jin QY; Connolly ID; Hayden Gephart M; You L
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292767
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
    Gonçalves CS; Xavier-Magalhães A; Martins EP; Pinto AA; Pires MM; Pinheiro C; Reis RM; Sousa N; Costa BM
    Mol Oncol; 2020 Jun; 14(6):1224-1241. PubMed ID: 31923345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma.
    Li Q; Liu X; Mao J; Liu S; Hou B; Li K; Fang D
    Biochem Biophys Res Commun; 2023 Oct; 676():149-157. PubMed ID: 37517217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma.
    Sun J; Wu S; Zhao W; Xue S; Zhang L; Ren J
    Front Oncol; 2024; 14():1307992. PubMed ID: 38322416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.
    Zhenjiang L; Rao M; Luo X; Valentini D; von Landenberg A; Meng Q; Sinclair G; Hoffmann N; Karbach J; Altmannsberger HM; Jäger E; Peredo IH; Dodoo E; Maeurer M
    EBioMedicine; 2018 Jul; 33():49-56. PubMed ID: 30049387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of
    Jiang H; Su Z; Hu W; Yuan X; Yu T; Yang J; Xiao X; Zheng S; Lin B
    OMICS; 2023 May; 27(5):215-226. PubMed ID: 37196148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
    Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
    Mala U; Baral TK; Somasundaram K
    BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
    Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
    Front Immunol; 2020; 11():1281. PubMed ID: 32765489
    [No Abstract]   [Full Text] [Related]  

  • 15. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
    Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLK3 Is Associated With Poor Prognosis in Patients With Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells.
    Zhu Y; Sun JM; Sun ZC; Chen FJ; Wu YP; Hou XY
    Front Oncol; 2020; 10():600762. PubMed ID: 33692940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Analysis of the Correlation of KIF2C with Prognosis and Immune Infiltration in Glioma.
    Tu B; Xiang H; Li M; Zhong F; Fang M; Yan W
    Comput Math Methods Med; 2022; 2022():6320828. PubMed ID: 35387222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.
    Sa JK; Chang N; Lee HW; Cho HJ; Ceccarelli M; Cerulo L; Yin J; Kim SS; Caruso FP; Lee M; Kim D; Oh YT; Lee Y; Her NG; Min B; Kim HJ; Jeong DE; Kim HM; Kim H; Chung S; Woo HG; Lee J; Kong DS; Seol HJ; Lee JI; Kim J; Park WY; Wang Q; Sulman EP; Heimberger AB; Lim M; Park JB; Iavarone A; Verhaak RGW; Nam DH
    Genome Biol; 2020 Aug; 21(1):216. PubMed ID: 32847614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade gliomas with isocitrate dehydrogenase wild-type and 1p/19q codeleted: Atypical molecular phenotype and current challenges in molecular diagnosis.
    Zheng L; Zhang M; Hou J; Gong J; Nie L; Chen X; Zhou Q; Chen N
    Neuropathology; 2020 Dec; 40(6):599-605. PubMed ID: 32761642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.